4//SEC Filing
LEVINE ARNOLD J 4
Accession 0001209191-21-035034
CIK 0001699382other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 5:38 PM ET
Size
7.0 KB
Accession
0001209191-21-035034
Insider Transaction Report
Form 4
LEVINE ARNOLD J
Director
Transactions
- Sale
Common Stock
2021-05-20$33.57/sh−539$18,092→ 426,803 total - Sale
Common Stock
2021-05-20$34.68/sh−2,961$102,676→ 423,842 total
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 27, 2021.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.22 to $34.215, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.22 to $35.145, inclusive.
Documents
Issuer
PMV Pharmaceuticals, Inc.
CIK 0001699382
Entity typeother
Related Parties
1- filerCIK 0001124164
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 5:38 PM ET
- Size
- 7.0 KB